Research Paper Volume 15, Issue 7 pp 2734—2771
Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma
Figure 5. The predicted ceRNA network of TSEN54 in HCC. (A) The Venn diagram demonstrates the miRNAs targeting TSEN54 predicted by TargetScan and RNAinter databases. The correlation scatter plots reveal the expression relevance of TSEN54 with (B) hsa-miR-27b-3p and (C) hsa-miR-125b-5p. Venn diagram illustrates the prediction of lncRNAs targeting (D) hsa-miR-27b-3p and (E) hsa-miR-125b-5p through miRNet and starBase tools. (F) Sankey diagram presents the ceRNA network of TSEN54 in HCC.